Diabetes drug shows promise for “blinding headache” condition
Exenatide, an injectable treatment for type 2 diabetes, has shown efficacy for the treatment of ‘blinding’ headaches known as idiopathic intercranial hypertension (IIH). Researchers from a phase 2 trial reported the finding on March 12, 2023 in the journal Brain. Lead investigator Alex Sinclair, Professor of Neurology in the Institute of Metabolism and Systems Research at the University of Birmingham […]
Recent Comments